FMF-03-145-1

FMF-03-145-1 : Inhibitor of AURKA, AURKB, AURKC

Structure

Information

  • AURKA
  • AURKB
  • AURKC
  • Inhibitor
  • up to 1 uM

In Vitro Validations

Uniprot ID: O14965
Target Class: Kinase
Target SubClass: Ser/Thr kinase
Potency: IC50
Potency Value: 52 nM
Potency Assay: Z’LYTE kinase assay
PDB ID for probe-target interaction (3D structure): 5ONE
Target aliases:
Aurora kinase A, STK6, STK15, IAK1, BTAK, AYK1, AU ...

DOI Reference: 10.1016/j.bmcl.2017.08.016

In Cell Validations

In Vivo Data

No in Vivo Validations

Off-Target Selectivity Assesments

Off Target: PLK4
Potency end-point : IC50 82 nM
Potency assay (off target): Exclusively on-target activity detected by KINOMEscan ® at 1 μ M compound concentration with only one off-target identified (PLK4).
I have extra information to add

SERP ratings and comments


SERP Ratings

In Cell Rating

SERP Comments:

An orthogonal PLK4 inhibitor should be used in parallel to rule out phenotypic effects that result from PLK4 inhibition.

(last updated: 23 Dec 2022 )

SERP Ratings

In Cell Rating

SERP Comments:

A great addition to known AURK inhibitors and worth using in cells for this family of kinases. With several AURK probes and inhibitors available, this should be used in combination with other structurally differentiated compounds.

(last updated: 3 Jan 2023 )

SERP+ Ratings

In Cell Rating

SERP+ Comments:

Considering that FMF-03-145-1 addresses the off-target PLK4 with an in vitro IC50 of 82 nM, which is comparable to the IC50 of the aurora kinases, an additional AURK probe with a different selectivity profile (no PLK4 inhibition) is necessary in cellular assays to ensure that cellular effects are not wrongfully attributed to AURK inhibition.

(last updated: 22 Mar 2023 )